Peptides

What are the main drawbacks in breast cancer early detection?

What is the breast cancer subtype with the worst clinical outcome?

Why are novel cellular targets important for targeted therapies?

Authors and Affiliations:

Vera L. Silva^1,2, Debora Ferreira¹, Franklin L. Nobrega¹, Ivone M. Martins¹, Leon D. Kluskens¹, Lígia R. Rodrigues¹

¹CEB—Centre of Biological Engineering, Universidade do Minho, Campus de Gualtar, Braga, Portugal

²School of Pharmacy—University of East Anglia, Norwich Research Park, Norwich, United Kingdom

Abstract: